American Scientific Reports in Neurological Disorders

Editor Name: Ion Codreanu

Designation: Associate Professor

Country: Republic of Moldova

Tel: + (373) 6769 3616

University: State University of Medicine and Pharmacy “NicolaeTestemitanu”

Biography:Dr. Codreanu completed his Master of Science (M.Sc.) and Doctor of Philosophy (D.Phil.) degrees in Medical Imaging at the University of Oxford in England. Subsequently he pursued a Nuclear Medicine residency at the Hospital of the University of Pennsylvania in Philadelphia, PA and a PET/CT fellowship at the University of Arizona Medical Center in Tucson, AZ. He is Board certified in Radiology, Nuclear Medicine and Nuclear Cardiology. Following his training in England and USA, Dr. Codreanu returned to his home country, serving as an Associate Professor of Radiology at the State University of Medicine and Pharmacy “Nicolae Testemitanu” in Chisinau, Moldova. Before returning to Moldova, he was a licensed medical practitioner in the states of Pennsylvania and Arizona. He is the author of over 60 peer review publications and several book chapters, being also awarded the title of Habilitated Doctor of Medicine.

Research Interest: Radiology and Medical Imaging

PUBLICATION:

1. Dasanu CA, Plaxe SC, Popescu IM, Gupta V, Sontz E, Codreanu I. Severe left atrial enlargement due to carfilzomib use in multiple myeloma. J Oncol Pharm Pract. 2019 Dec;25(8):2045-2048. doi: 10.1177/1078155218825298.

2. Dasanu CA, Del Rosario M, Codreanu I, Lu Y, Farrell S, Plaxe SC. Merkel cell carcinoma: long-term follow-up and clinical outcomes by immunological status. Dermatol Online J. 2019 Feb 15;25(2).

3. Dasanu CA, Del Rosario M, Codreanu I, Hyams DM, Plaxe SC. Inferior outcomes in immunocompromised Merkel cell carcinoma patients: Can they be overcome by the use of PD1/PDL1 inhibitors? J Oncol Pharm Pract. 2019 Jan;25(1):214-216. doi: 10.1177/1078155218785002.

4. Dasanu CA, Alvarez-Argote J, Limonadi FM, Codreanu I. Bevacizumab in refractory higher-grade and atypical meningioma: the current state of affairs. Expert OpinBiolTher. 2019 Feb;19(2):99-104. doi: 10.1080/14712598.2019.1559292

5. Dasanu CA, Samara Y, Codreanu I, Limonadi FM, Hamid O, Alvarez-Argote J. Systemic therapy for relapsed/refractory meningioma: Is there potential for antiangiogenic agents? J Oncol Pharm Pract. 2019 Apr;25(3):638-647. doi: 10.1177/1078155218799850.

6. Rotaru N, Malîga O, Codreanu I. Harmonization of educational management in radiology and medical imaging in the Republic of Moldova with international standards. Moldovan Journal of Health Sciences. 2017;13(3):66-78

7. Rotaru N, Crivcheanschii M, Condrea E, Seu V, Codreanu I. Temporomandibular joint deformities and atlantoaxial impaction in rheumatoid arthritis. Journal of Case Reports: Clinical & Medical. 2017; 1(1):111

and many more…